Effect of CommonCYP3A4andCYP3A5Variants on the Pharmacokinetics of the CytochromeP450 3A Phenotyping Probe Midazolam in Cancer Patients-Reference-Cited by-同舟云学术

Effect of CommonCYP3A4andCYP3A5Variants on the Pharmacokinetics of the CytochromeP450 3A Phenotyping Probe Midazolam in Cancer Patients

Published:2005-10-15 Issue:20 Volume:11 Page:7398-7404
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lepper Erin R.,Baker Sharyn D.,Permenter Matt,Ries Nicole,van Schaik Ron H.N.,Schenk Paul W.,Price Douglas K.,Ahn Danielle,Smith Nicola F.,Cusatis George,Ingersoll Roxann G.,Bates Susan E.,Mathijssen Ron H.J.,Verweij Jaap,Figg William D.,Sparreboom Alex

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A4*22 and CYP3A5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome;Nordic Journal of Psychiatry;2022-04-26

2. Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome;Psychiatric Genetics;2022-01-06

3. CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women;Cancers;2021-09-18

4. Relations of CYP2C19*2 genetic polymorphisms to plasma and saliva concentrations of diazepam in patients hospitalized for alcohol withdrawal;Personalized Psychiatry and Neurology;2021-05-15

5. Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir;The Pharmacogenomics Journal;2021-03-01